Patents Assigned to AERIN MEDICAL, INC.
-
Publication number: 20190201069Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: March 8, 2019Publication date: July 4, 2019Applicant: AERIN MEDICAL, INC.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Patent number: 10335221Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: August 25, 2017Date of Patent: July 2, 2019Assignee: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20190175242Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: February 12, 2019Publication date: June 13, 2019Applicant: AERIN MEDICAL, INC.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Publication number: 20190151005Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: January 24, 2019Publication date: May 23, 2019Applicant: AERIN MEDICAL, INC.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Patent number: 10265115Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: September 6, 2017Date of Patent: April 23, 2019Assignee: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20180344378Abstract: A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.Type: ApplicationFiled: July 20, 2018Publication date: December 6, 2018Applicant: AERIN MEDICAL, INC.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Publication number: 20180228533Abstract: Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.Type: ApplicationFiled: April 13, 2018Publication date: August 16, 2018Applicant: Aerin Medical Inc.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Patent number: 10028780Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: April 6, 2017Date of Patent: July 24, 2018Assignee: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20180177542Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: February 23, 2018Publication date: June 28, 2018Applicant: AERIN MEDICAL, INC.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Patent number: 9943361Abstract: Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.Type: GrantFiled: May 16, 2017Date of Patent: April 17, 2018Assignee: AERIN MEDICAL INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Patent number: 9913682Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: December 15, 2016Date of Patent: March 13, 2018Assignee: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Patent number: 9888957Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: June 7, 2016Date of Patent: February 13, 2018Assignee: AERIN MEDICAL INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20180000535Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: August 25, 2017Publication date: January 4, 2018Applicant: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20170360495Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: ApplicationFiled: September 6, 2017Publication date: December 21, 2017Applicant: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Patent number: 9801752Abstract: Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.Type: GrantFiled: July 21, 2016Date of Patent: October 31, 2017Assignee: AERIN MEDICAL, INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Patent number: 9788886Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.Type: GrantFiled: September 21, 2016Date of Patent: October 17, 2017Assignee: AERIN MEDICAL INC.Inventors: Scott J. Wolf, Andrew Frazier
-
Publication number: 20170252100Abstract: A device is described for treating a nasal airway by modifying a property of a nasal tissue of or near a nasal valve of the airway, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in the nasal airway. Various embodiments include an elongate shaft, a bipolar radiofrequency delivery member extending from one end of the shaft, and a handle attached to the elongate shaft at an opposite end from the radiofrequency delivery member. The radiofrequency delivery member is sized to be inserted into a nose and configured to at least temporarily deform the nasal tissue and deliver radiofrequency energy. The radiofrequency delivery member includes two rows of protruding electrodes disposed on a tissue contact surface, and the device is configured to deliver radiofrequency energy from one row of electrodes to the other row of electrodes.Type: ApplicationFiled: May 16, 2017Publication date: September 7, 2017Applicant: Aerin Medical Inc.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Publication number: 20170252089Abstract: Disclosed embodiments relate to devices, systems, and methods of shaping, shrinking, opening, dilating, stiffening, or otherwise modifying a Eustachian tube and its surrounding tissue in order to improve the Eustachian tube's function. For example, patients with blocked, closed, or hypertrophic Eustachian tubes may be able to achieve improved function including easier equalization of pressure between the inner ear and environment.Type: ApplicationFiled: March 3, 2017Publication date: September 7, 2017Applicant: Aerin Medical, Inc.Inventors: Jerome Hester, Andrew Frazier, Gregory Ng, Scott J. Wolf
-
Publication number: 20170245924Abstract: Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.Type: ApplicationFiled: May 16, 2017Publication date: August 31, 2017Applicant: Aerin Medical Inc.Inventors: Scott J. WOLF, Andrew FRAZIER
-
Publication number: 20170231651Abstract: Disclosed embodiments include devices and methods for shaping, bending, and/or volumetrically reducing rigid cartilaginous structures, such as hyaline cartilage in the septum. In the case of septal cartilage, shaping, bending, or reducing the cartilage would be useful for reducing nasal obstruction or to improve the cosmetic appearance of the nose.Type: ApplicationFiled: February 10, 2017Publication date: August 17, 2017Applicant: Aerin Medical, Inc.Inventors: Fred DINGER, Andrew FRAZIER